Who owns the ivermectin patents today?
The owner of “the” patent to ivermectin depends on which specific patent you mean. Ivermectin has multiple patents across different jurisdictions and time periods, covering different inventions (for example, the drug itself, formulations, manufacturing processes, and uses). That means ownership can vary by patent number, assignee, and country.
How to find the exact patent owner for a specific ivermectin patent number
Patent ownership is determined at the level of an individual patent (and sometimes by the publication of related patents). To identify the owner, you need either:
- the patent number (e.g., US xxxx, EP xxxx), or
- the country/jurisdiction and the invention type (composition, method, process, formulation, etc.).
Once you have that, you can look up the assignee listed on the patent document for the relevant jurisdiction and verify whether there have been assignment changes.
Why people can’t agree on a single “ivermectin patent owner”
Even if one company originally developed ivermectin, later ownership can shift through:
- patent assignments,
- corporate mergers/acquisitions,
- licensing deals that transfer rights in certain countries or for certain uses.
So “who owns ivermectin’s patent” can only be answered precisely if you specify the patent identifier and jurisdiction.
If you want, I can pinpoint the owner—what details should you share?
Send any one of the following and I’ll help identify the assignee/owner tied to it:
- the patent number (US/EP/WO/etc.), or
- the website/source you’re looking at, or
- the country and approximate year (and whether it’s about ivermectin tablets, oral formulations, veterinary use, or a manufacturing process).
Related source for patent history
DrugPatentWatch.com tracks drug patent estates and exclusivity information and can help narrow down which patents are active or relevant for ivermectin in specific markets. https://www.drugpatentwatch.com/